This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2016 Jan;56(1):19-22.

doi: 10.1111/trf.13411.

Can we "terminate" alloimmune platelet transfusion refractoriness?

Ralph R Vassallo¹, Philip J Norris²

Affiliations

PMID: 26756708
DOI: 10.1111/trf.13411

Editorial

Can we "terminate" alloimmune platelet transfusion refractoriness?

Ralph R Vassallo et al. Transfusion. 2016 Jan.

. 2016 Jan;56(1):19-22.

doi: 10.1111/trf.13411.

Authors

Ralph R Vassallo¹, Philip J Norris²

Affiliations

¹ Blood Systems, Inc., Scottsdale, AZ.
² Blood Systems Research Institute, San Francisco, CA.

PMID: 26756708
DOI: 10.1111/trf.13411

No abstract available

PubMed Disclaimer

Comment on

Transfusion-induced alloimmunization and platelet refractoriness in a mouse model: mechanisms and interventions.
Waterman HR, Kapp LM, Munday A, Odem-Davis K, Zimring JC. Waterman HR, et al. Transfusion. 2016 Jan;56(1):91-100. doi: 10.1111/trf.13270. Epub 2015 Sep 24. Transfusion. 2016. PMID: 26400622

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information